Table 2.
Changes in Cardiovascular Risk Factors During the Study.
| T1D patients |
T2D patients |
|||
|---|---|---|---|---|
| V0 | V5 | V0 | V5 | |
| Waist (cm) | 88.7 ± 11.9 | 87.4 ± 11.9 | 101.7 ± 12.8 | 101.3 ± 11.9 |
| Systolic BP (mmHg) | 120.5 ± 16.2 | 121.4 ± 14.8 | 136.3 ± 19.5 | 136.6 ± 15.6 |
| Diastolic BP (mmHg) | 75.9 ± 8.2 | 77.1 ± 5.9 | 82.6 ± 9.8 | 82.3 ± 8.6 |
| Total chol (mmol/l) | 5.04 ± 0.89 | 5.55 ± 1.02a | 5.68 ± 1.35 | 5.84 ± 1.19a |
| LDL chol (mmol/l) | 2.92 ± 0.73 | 3.36 ± 0.91a | 3.31 ± 0.99 | 3.52 ± 0.98a |
| HDL chol (mmol/l) | 1.41 ± 0.38 | 1.49 ± 0.35 | 1.21 ± 0.38 | 1.26 ± 0.39a |
| Triglycerides (mmol/l) | 1.48 ± 0.79 | 1.56 ± 0.98 | 2.91 ± 2.44 | 2.52 ± 2.01a |
| UAE 30-300 mg/24h | 91.8 ± 21.9 | 65.3 ± 31.5 | 92.5 ± 6.6 | 120.4 ± 13.7 |
| UAE > 300 (% of pts) | 5.3 | 7.8 | 9.8 | 8.8 |
Data are expressed as mean ± SD, unless otherwise noted. BP, blood pressure; chol, cholesterol; pts, patients; T1D, type 1 diabetes; T2D, type 2 diabetes; UAE, urinary albumin excretion.
a
P < .01 vs V0.